U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 150

Tests names and labsConditionsGenes, analytes, and microbesMethods

NGS Panel for Fanconi anemia

BloodGenetics
Spain
2222
  • C Sequence analysis of the entire coding region

BRCA2 Gene Sequencing

Michigan Medical Genetics Laboratories University of Michigan Medical School
United States
71
  • C Sequence analysis of the entire coding region

Common Hereditary Cancer Screening Panel

PreventionGenetics
United States
9455
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

BRCA2 - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
81
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCA2 - MLPA

Centogene US, LLC - The Rare Disease Company
United States
81
  • D Deletion/duplication analysis

BRCA1 & BRCA2 - MLPA

Centogene US, LLC - The Rare Disease Company
United States
112
  • D Deletion/duplication analysis

BRCA1, BRCA2

Centogene US, LLC - The Rare Disease Company
United States
112
  • C Sequence analysis of the entire coding region

BRCA1, BRCA2 Plus

Centogene US, LLC - The Rare Disease Company
United States
112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCA1, BRCA2 Combi

Centogene US, LLC - The Rare Disease Company
United States
112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoBreast

Centogene US, LLC - The Rare Disease Company
United States
5828
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoColon

Centogene US, LLC - The Rare Disease Company
United States
6733
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer

Centogene US, LLC - The Rare Disease Company
United States
11468
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer Comprehensive

Centogene US, LLC - The Rare Disease Company
United States
156107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCA1, BRCA2 Somatic

Centogene US, LLC - The Rare Disease Company
United States
112
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene US, LLC - The Rare Disease Company
United States
218135
  • C Sequence analysis of the entire coding region

BRCA1, BRCA2

Centogene AG - the Rare Disease Company
Germany
112
  • C Sequence analysis of the entire coding region

BRCA1, BRCA2 Plus

Centogene AG - the Rare Disease Company
Germany
112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCA1, BRCA2 Combi

Centogene AG - the Rare Disease Company
Germany
112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoBreast

Centogene AG - the Rare Disease Company
Germany
5828
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoColon

Centogene AG - the Rare Disease Company
Germany
6733
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 150

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.